Monday Mar 10
Research and Markets: Investigation Report on China's Tacrolimus Market, 2009-2018
Tacrolimus, also named as ""FK506"" and ""FR-900506"", was developed by Fujisawa Pharmaceutical Co., Ltd. .
Veloxis Pharmaceuticals Announces NDA Submission for EnvarsusA in Kidney Transplant Recipients
The submission is based on the entire data set from the company's clinical development program that comprised 25 studies and enrolled over 1000 patients, including two pivotal clinical trials, studies 3001 and 3002.
FDA awards $2.25M grant to study immunosuppresive drug in high-risk patients
Transplant researchers at the University of Cincinnati have received a grant from the U.S. Food and Drug Administration to study the safety and efficacy of a generic immunosuppressive drug in high-risk transplant patients.